These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1362267)
61. The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy. Engleman EA; Rodd ZA; Bell RL; Murphy JM CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):454-67. PubMed ID: 19128203 [TBL] [Abstract][Full Text] [Related]
66. Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience. Canto-de-Souza A; Luiz Nunes-de-Souza R; Rodgers RJ Brain Res; 2002 Feb; 928(1-2):50-9. PubMed ID: 11844471 [TBL] [Abstract][Full Text] [Related]
68. Preclinical pharmacology of FG5893: a potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors. Albinsson A; Björk A; Svartengren J; Klint T; Andersson G Eur J Pharmacol; 1994 Aug; 261(3):285-94. PubMed ID: 7813550 [TBL] [Abstract][Full Text] [Related]
69. Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants. Levy AD; Van de Kar LD Life Sci; 1992; 51(2):83-94. PubMed ID: 1352027 [TBL] [Abstract][Full Text] [Related]
70. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron. Barnes JM; Barnes NM Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263 [TBL] [Abstract][Full Text] [Related]
71. Distribution and characterisation of the [3H](S)-zacopride labelled 5-HT3 receptor in pig forebrain. Fletcher S; Barnes NM Brain Res; 1996 Aug; 729(2):281-4. PubMed ID: 8877001 [TBL] [Abstract][Full Text] [Related]
72. The role of 5-HT3 receptors in drug dependence. Grant KA Drug Alcohol Depend; 1995 May; 38(2):155-71. PubMed ID: 7671767 [TBL] [Abstract][Full Text] [Related]
73. Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test. Redrobe JP; Bourin M Eur J Pharmacol; 1997 May; 325(2-3):129-35. PubMed ID: 9163559 [TBL] [Abstract][Full Text] [Related]
74. [Pharmacological review of tropisetron]. Yokoyama T Nihon Yakurigaku Zasshi; 1999 Oct; 114(4):219-26. PubMed ID: 10584235 [TBL] [Abstract][Full Text] [Related]
75. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset. Costall B; Domeney AM; Farre AJ; Kelly ME; Martinez L; Naylor RJ J Pharmacol Exp Ther; 1992 Jul; 262(1):90-8. PubMed ID: 1352556 [TBL] [Abstract][Full Text] [Related]
76. Effects of 5-HT3 receptor antagonists on 5-HT and nicotinic depolarizations in guinea-pig submucosal neurones. Vanner S; Surprenant A Br J Pharmacol; 1990 Apr; 99(4):840-4. PubMed ID: 2141798 [TBL] [Abstract][Full Text] [Related]
77. Comparison of potencies of 5-HT3 receptor antagonists at inhibiting aversive behavior to illumination and the von Bezold-Jarisch reflex in the mouse. Eglen RM; Lee CH; Khabbaz M; Fontana DJ; Daniels S; Kilfoil T; Wong EH Neuropharmacology; 1994 Feb; 33(2):227-34. PubMed ID: 8035908 [TBL] [Abstract][Full Text] [Related]